Perioperative pain therapy in opioid abuse

European Journal of Anaesthesiology

Volumn 30, Issue 2, 2013, Pages 55-64

  Stromer, Waltraud ^a   Michaeli, Kristina ^b   Sandner Kiesling, Andreas ^b  

^a Landesklinikum Waldviertel Horn ^*  (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Addictive disease; Anaesthesia; Analgesia; Comorbidity; Opioid withdrawal syndrome; Perioperative analgesic concept

Indexed keywords

ALFENTANIL; AMITRIPTYLINE; CLONIDINE; DOXEPIN; FENTANYL; FLUMAZENIL; GABAPENTIN; KETAMINE; METHADONE; NALOXONE; NEOSTIGMINE; PLACEBO; PREGABALIN; REMIFENTANIL; SUFENTANIL;

ANALGESIC ACTIVITY; ANESTHESIA; CHRONIC PAIN; COMORBIDITY; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; DRUG USE; EMOTIONAL STRESS; ENVIRONMENTAL FACTOR; EPIDURAL ANESTHESIA; EVENING DOSAGE; GENERAL ANESTHESIA; HUMAN; HYPERALGESIA; LONG TERM CARE; MEDICAL HISTORY; MENTAL STRESS; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PAIN THRESHOLD; PATIENT CONTROLLED ANALGESIA; PERIOPERATIVE PERIOD; PHYSICAL STRESS; POSTOPERATIVE PAIN; PREMEDICATION; PSYCHOLOGICAL ASPECT; REGIONAL ANESTHESIA; REVIEW; SYNAPTIC TRANSMISSION; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; HUMANS; PAIN, POSTOPERATIVE;

EID: 84876238873     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32835b822b     Document Type: Review

References (70)

1. ÖBIG. Bericht zur Drogensituation 2009. Österreichisches Bundesinstitut für Gesundheitswesen. Wien; 2010.
2. Kopf A, Banzhof A, Stein C. Perioperative management of the chronic pain patient. Best Pract Res Clin Anaesthesiol 2005; 19:59-76.
3. Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007; 11:490-518.
4. Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification (review). Cochrane Database Syst Rev 2011: CD005031.
5. Fitzgibbon D, Rathmell J, Michna E, et al. Malpractice claims associated with medication management for chronic pain. Anesthesiology 2010; 112:948-956.
6. Hakkarainen P, Metso L. Joint use of drugs and alcohol. Eur Addict Res 2009; 15:113-120.
7. Edgerton L, Loven B, Mounsey A. What are the adverse effects of prolonged opioid use in patients with chronic pain? J Fam Pract 2011; 60:288-289.
8. Fiellin DA, Kleber H, Trumble-Hejduk JG, et al. Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat 2004; 27:153-159.
9. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349:1943-1953.
10. Celerier E, Laulin JP, Corcuff JB, et al. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J Neurosci 2001; 21:4074-4080.
11. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage 2004; 28:176-188.
12. Ready LB. Postoperative pain management meets addiction medicine. Acute Pain 2000; 3:181-182.
13. Streltzer J. Pain management in the opioid-dependent patient. Curr Psychiatry Rep 2001; 3:489-496.
14. Lazareck S, Robinson J, Crum R, et al. A longitudinal investigation of the role of self-medication in the development of comorbid mood and drug use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Disorders (NESARC). J Clin Psychiatry 2012; 73:e588-e593.
15. Bonnet U, Gastpar M. Opioide. In: Gastpar M, Mann K, Rommelsbacher H, editors. Lehrbuch der Suchterkrankungen. Stuttgart: Thieme; 1999. pp. 237-262.
16. Koob GF, Ahmed SH, Boutrel B, et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 2004; 27:739-749.
17. Jaffe JH. Drug addiction and drug abuse. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press; 1990. pp. 522-573.
18. Nestler EJ. Molecular mechanisms of drug addiction. Neuropharmacol 2004; 47:24-32.
19. Treede D. Neural basis of pain. In: Smelser NJ, Baltes PB, editors. International encyclopaedia of the social & behavioral sciences. Amsterdam: Elsevier; 2001. pp. 11000-11005.
20. Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 1998; 51:23-27.
21. Koppert W, Ihmsenn H, Korber N, et al. Different profiles of buprenorphineinduced analgesia and antihyperalgesia in a human pain model. Pain 2005; 118:15-22.
22. Beattie CH, Mark L, Umbricht-Schneiter A. Evaluation of the patient with alcoholism and other dependencies. In: Longnecker DE, Tinker JH, Morgan GE, editors. Principles and practice of anesthesiology. 2nd ed. St Louis, Missouri: Mosby; 1998. pp. 537-565.
23. Mitra S, Sinatra RS, Herz A. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology 2004; 101:212-227.
24. Rapp SE, Ready LB, Nessly ML. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review. Pain 1995; 61:195-201.
25. Koppert W. Opioid induced hyperalgesia. Anaesthesist 2004; 53: 455-466.
26. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 2002; 100:213-217.
27. Vanderah TW, Ossipov MH, Lai J, et al. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain 2001; 92:5-9.
28. Angst MS, Koppert W, Pahl I, et al. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003; 106:49-57.
29. Doverty M, White JM, Somogyi AA, et al. Hyperalgesic responses in methadone maintenance patients. Pain 2001; 90:01-96.
30. Doverty M, Somogyi AA, White JM, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 2001; 93:155-163.
31. Konopka K, van Wijhe M. Opioid-induced hyperalgesia: pain hurts? Br J Anaesth 2010; 105:555-557.
32. Compton P, Athanasos LC, Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. J Pain 2003; 4:511-519.
33. Laulin JP, Maurette P, Corcuff JB, et al. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 2002; 94:1263-1269.
34. Koppert W, Wehrfritz A, Korber N, et al. The cyclooxygenase isoenzyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain 2004; 108:148-153.
35. Jage J, Heid F. Anaesthesia and analgesia in addicted patients. Anaesthesist 2006; 55:611-628.
36. May JA, White HC, Leonard-White A, et al. The patient recovering from alcohol or drug addiction: special issues for the anesthesiologist. Anesth Analg 2001; 92:1601-1608.
37. Kienbaum P, Thürauf N, Michel MS, et al. Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology 1998; 88:1154-1161.
38. Manning BH, Merin NM, Meng ID, Amaral DG. Reduction in opioid- and cannabinoid-induced antinociception in rhesus monkeys after bilateral lesions of the amygdaloid complex. J Neurosci 2001; 21:8238-8246.
39. Neugebauer V, Li W, Bird GC, Hans JS. The amygdala and persistent pain. Neurosci 2004; 10:221-234.
40. Breese GR, Chu K, Dayas CV, et al. Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res 2005; 29:185-195.
41. Bradley BP, Gossop M, Phillips GT, Legarda JJ. The development of an opiate withdrawal scale (OWS). Br J Addict 1987; 82:1139-1142.
42. Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs 2003; 35:235-259.
43. Wallner C, Stöllberger C, Hlavin A, et al. Electrocardiographic abnormalities in opiate addicts. Addiction 2008; 103:1987-1993.
44. Reimer J, Verthein U, Karow A, et al. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Addiction 2011; 106:1647-1655.
45. Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Recent findings. Arch Gen Psychiatr 1985; 42:1067-1071.
46. Caumo W, Schmidt AP, Schneider CN, et al. Preoperative predictors of moderate to intense acute postoperative pain in patients undergoing abdominal surgery. Acta Anaesthesiol Scand 2002; 46:1265-1271.
47. Dersh J, Polantin PB, Gatchel RJ. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med 2002; 64:773-786.
48. Kalkman CJ, Visser K, Moen J, et al. Preoperative prediction of severe postoperative pain. Pain 2003; 105:415-423.
49. Reymann G, Gastpar M. Opioidbezogene Störungen. In: Schmidt LG, Gastpar M, Falkai P, Gaebel W, editors. Evidenzbasierte Suchtmedizin. Köln: Deutscher Ärzte-Verlag; 2006. pp.171-239.
50. Werner W. Substitutionstherapie. In: Beubler E, Haltmayer H, Springer A, editors. Opioidabhä ngigkeit: Interdisziplinäre Aspekte für die Praxis. Wien: Springer; 2006. pp. 185-203.
51. Scherbaum N, Finkbeiner T, Leifert K, Gastpar M. The efficacy of Lmethadone and racemic methadone in substitution treatment for opiate addicts: a double-blind comparison. Pharmacopsychiatry 1996; 29 212-215.
52. Shaheen PE, Walsh D, Lasheen W, et al. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manage 2009; 38: 409-417.
53. Vissers KCP, Besse K, Hans G, et al. Opioid rotation in the management of chronic pain: where is the evidence? Pain Pract 2010; 10:85-93.
54. Davies E, Gastpar M. Buprenorphine in the treatment of opioid dependence. Eur Neuropsychopharmacol 2004; 14:209-216.
55. Jage J, Bey T. Postoperative analgesia in patients with substance use disorders. Acute Pain 2000; 3:140-155; 172-180.
56. Jage J, Jurna I. Opioidanalgetika. In: Zenz M, Jurna I, editors. Lehrbuch der Schmerztherapie. 2. Aufl. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2001. pp. 255-280.
57. de Leon-Casasola OA. Cellular mechanisms of opioid tolerance and the clinical approach to the opioid tolerant patient in the postoperative period. Best Pract Res Clin Anaesthesiol 2002; 16:521-525.
58. Carrol IR, Angst MS, Clark JD. Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med 2005; 29:576-591.
59. Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care 2011; 39:804-823.
60. de Leon-Casasola OA, Lema MJ. Epidural sufentanil for acute pain control in a patient with extreme opioid dependency. Anesthesiology 1992; 76:853-856.
61. Motsch J, Graber E, Ludwig K. Addition of clonidine enhances postoperative analgesia from epidural morphine: a double-blind study. Anesthesiology 1990; 73:1067-1073.
62. Jaksch W. Opiatabhä ngigkeit und Schmerztherapie. In: Beubler E, Haltmayer H, Springer A, editors. Opioidabhä ngigkeit: Interdisziplinä re Aspekte für die Praxis. Wien: Springer; 2006. pp. 251-257.
63. Gowing L, Ali R, White JM. Opioid antagonists with minimal sedation for opioid withdrawal (review). Cochrane Database Syst Rev 2009:CD002021.
64. Haller G, Waeber J-L, Infante NK, Clergue F. Ketamine combined with morphine for the management of pain in an opioid addict. Anesthesiology 2002; 96:1265-1266.
65. Himmelseher S, Durieux ME. Ketamine for perioperative pain management. Anesthesiology 2005; 102:211-220.
66. Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg 2002; 183:630-641.
67. Freedman BM, O'Hara E. Pregabalin has opioid-sparing effects following augmentation mammaplasty. Aesthet Surg J 2008; 28:421-424.
68. Buvanendran A, Kroin JS, Della Valle CJ, et al. Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial. Anesth Analg 2010; 110:199-207.
69. Weissman DE, Haddox JD. Opioid pseudoaddiction: an iatrogenic syndrome. Pain 1989; 36:363-366.
70. Strang J, McCambridge J, Best D, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. Br Med J 2003; 326:959-960.